Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis

Rainer Klocke, Kirsty Levasseur, George D Kitas, Jacqueline P Smith, George Hirsch, Rainer Klocke, Kirsty Levasseur, George D Kitas, Jacqueline P Smith, George Hirsch

Abstract

Intra-articular corticosteroid injections (IACI) are commonly used interventions for pain relief in patients with knee osteoarthritis (OA). Biomarkers may be helpful in further elucidating how IACI exert their effect. The aim of this study is to look at the response of biomarkers of cartilage and bone metabolism after IACI in knee OA. Eighty subjects with symptomatic knee OA [45% male, mean age (SD) 64 (11) years] underwent routine knee joint injection with 40 mg triamcinolone acetonide and 4 ml 1% lignocaine. Knee pain (as pain subscale of WOMAC VAS) and biomarkers [C-telopeptides of type-II collagen (uCTX-II), and N-telopeptides of type-I collagen in urine; cartilage oligomeric matrix protein (COMP), hyaluronic acid, N-terminal propeptide of type-IIA collagen, and human cartilage glycoprotein-39 (YKL-40) in serum] were measured at baseline and 3 weeks after IACI. Radiographic severity of disease was evaluated using knee radiographs. Median uCTX-II, a cartilage degradation marker, was lower at 3 weeks post IACI compared with baseline: 306.3 and 349.9 ng/mmol, respectively (p < 0.01), which remained significant after Bonferroni correction. Apart from a weak trend of lower sCOMP post IACI (p = 0.089), other biomarkers showed no change after IACI. Both baseline uCTX-II values and the change in uCTX-II from baseline to 3 weeks post injection correlated with radiographic severity of joint space narrowing, but not osteophyte grade. No association between uCTX-II and pain was observed. This observational study suggests that IACI in knee OA may reduce cartilage degradation in the short term.

Keywords: Biomarker; Intra-articular corticosteroid; Knee osteoarthritis; Urine CTX-II.

References

    1. Juni P, Hari R, Rutjes AW, Siletta MG, Reichenbach S. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2013;10:CD005328.
    1. Hirsch G, Kitas G, Klocke R. Intra-articular corticosteroid injection in osteoarthritis of the knee and hip: factors predicting pain relief—a systematic review. Semin Arthritis Rheum. 2013;42(5):451–473. doi: 10.1016/j.semarthrit.2012.08.005.
    1. Lafeber FPJG, van Spil WE. Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Osteoarthr Cartil [Internet] 2013;21(10):1452–1464. doi: 10.1016/j.joca.2013.08.012.
    1. Lotz M, Martel-Pelletier J, Christiansen C, Brandi M-L, Bruyère O, Chapurlat R, et al. Republished: value of biomarkers in osteoarthritis: current status and perspectives. Postgrad Med J [Internet] 2014;90(1061):171–178. doi: 10.1136/postgradmedj-2013-203726rep.
    1. Valdes AM, Meulenbelt I, Chassaing E, Arden NK, Bierma-Zeinstra S, Hart D, et al. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Osteoarthr Cartil [Internet] 2014;22(5):683–689. doi: 10.1016/j.joca.2014.02.007.
    1. Van Spil WE, Welsing PMJ, Bierma-Zeinstra SMA, Bijlsma JWJ, Roorda LD, Cats HA, et al. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthr Cartil [Internet] 2015;23(8):1388–1397. doi: 10.1016/j.joca.2015.03.023.
    1. Van Spil WE, Nair SC, Kinds MB, Emans PJ, Hilberdink WKHA, Welsing PMJ, et al. Systemic biochemical markers of joint metabolism and inflammation in relation to radiographic parameters and pain of the knee: data from CHECK, a cohort of early-osteoarthritis subjects. Osteoarthr Cartil [Internet] 2015;23(1):48–56. doi: 10.1016/j.joca.2014.09.003.
    1. Altman RD, Bloch DA, Bole GGJ, Brandt KD, Cooke DV, Greenwald RA, et al. Development of clinical criteria for osteoarthritis. J Rheumatol. 1987;14 Spec No:3–6.
    1. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–1840.
    1. Burnett DJ, Hart DJ, Cooper CSA. A radiographic atlas of osteoarthritis. London: Springer; 1994.
    1. Kumm J, Tamm A, Lintrop M, Tamm A. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects. Rheumatol Int. 2013;33(4):903–911. doi: 10.1007/s00296-012-2463-8.
    1. Wiegant K, Van Roermund PM, Intema F, Cotofana S, Eckstein F, Mastbergen SC, et al. Sustained clinical and structural benefit after joint distraction in the treatment of severe knee osteoarthritis. Osteoarthr Cartil [Internet] 2013;21(11):1660–1667. doi: 10.1016/j.joca.2013.08.006.
    1. Conrozier T, Balblanc JC, Richette P, Mulleman D, Maillet B, Henrotin Y, et al. Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: an open-label observational prospective study. J Orthop Res. 2012;30(5):679–685. doi: 10.1002/jor.21580.
    1. Pelletier JP, Mineau F, Raynauld JP, Woessner JFJ, Gunja-Smith Z, Martel-Pelletier J. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum. 1994;37(3):414–423. doi: 10.1002/art.1780370316.
    1. Piper SL, Kramer JD, Kim HT, Feeley BT. Effects of local anesthetics on articular cartilage. Am J Sports Med. 2011;39(10):2245–2253. doi: 10.1177/0363546511402780.
    1. Raynauld J-P, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum [Internet] 2003;48(2):370–377. doi: 10.1002/art.10777.
    1. McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967–1975. doi: 10.1001/jama.2017.5283.
    1. Bijlsma JWJ, Berenbaum F, Lafeber FPJG, Osteoarthritis An update with relevance for clinical practice. Lancet. 2011;377(9783):2115–2126. doi: 10.1016/S0140-6736(11)60243-2.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir